본문 바로가기 주메뉴 바로가기 보조메뉴 바로가기 푸터 바로가기

Archive

Newsletter

From the Manufacturing, To the competitiveness

  • Author : 관리자
  • Date : 26-08-04
  • Read : 72

Global No.1 Microneedle

Raphas ODM Sales Team

Perfecting your beauty innovation with premium quality and rational costs.

 

Greetings from Raphas ODM Division, the global No.1 microneedle specialist.


As the beauty market rapidly shifts towards high-mix, low-volume production, many brands face 

the challenge of developing highly efficacious products while efficiently managing manufacturing costs. 


Deeply understanding these practical concerns, 

Raphas introduces our unrivaled manufacturing capabilities designed to deliver 

our high-efficacy microneedle products at top-tier quality and reasonable prices.


 

1Government-Certified Producer of "Next-Generation World-Class Products"


In 2016, Raphas became the first in the domestic microneedle industry to be selected as a producer of 

"Next-Generation World-Class Products" for our 'Hyaluronic Acid Microneedle Patch.' 


We reaffirmed this prestigious status once again in 2024. This official recognition by the Korean government validates 

our unrivaled technological prowess and exceptional global export performance.


2Unrivaled Cost & Quality Competitiveness via Advanced Smart Factory


Since participating in the government's smart factory support project in 2019, 

our Cheonan plant has completely digitized analog processes and successfully integrated AI systems into core operations. 


Through real-time process monitoring, data-driven yield analysis, and predictive maintenance, 
we have achieved groundbreaking cost reductions and yield improvements.


As a result, despite the global trend of rising raw material and labor costs, 

we continue to provide higher quality products stably without increasing supply prices for our long-term partner clients.


 Based on these innovative achievements, Raphas was awarded 

the "2025 Manufacturing Innovation Excellence Company" at the Technology Innovation Exhibition.



3Setting a New Paradigm with the Industry's First 'Autonomous Factory'


Not resting on our current success, Raphas' continuous investment and innovation were recognized 
by being proudly selected for the government-led 'Autonomous Factory Support Project' starting in July 2026. 

By introducing AI-based quality prediction systems to core processes and applying Digital Twin technology across all operations, 
we plan to complete a perfect autonomous manufacturing environment capable of real-time, two-way control.

Through this, we will secure top-tier infrastructure capable of unmanned production, 
expanding beyond cosmetics to pharmaceuticals and vaccines, 
thereby providing our clients with the highest quality products at the lowest possible cost.



Raphas' manufacturing competitiveness, backed by the smartest infrastructure,
will soon become your business competitiveness.

We look forward to growing together with innovative brand clients to introduce
microneedle products of overwhelming quality to consumers worldwide.


Thank you.

Raphas ODM Sales Team